GNI Group Ltd.
SEC insider (Form 3/4/5 filer). CIK 0001958461. 10% Owner at GYRE THERAPEUTICS, INC. (GYRE). 2 reported Form 4/5 transactions since Sep 2024; latest on May 4, 2026. Located in TOKYO.
Companies GNI Group Ltd. has filed insider reports for
- GYRE THERAPEUTICS, INC. (GYRE): 10% Owner
GNI Group Ltd.
CIK: 0001958461
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GYRE
GYRE THERAPEUTICS, INC.
10% Owner